THE UNIVERSITY OF KENTUCKY joined the TriNetX network for its clinical trial design and clinical research. Pharmaceutical researchers will gain access to the university’s clinical data through TriNetX’s network of healthcare institutions representing over 37 million patients in the U.S. and Europe to support clinical study and protocol design, site selection, and patient recruitment across...
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
